Mild Cognitive Impairment and Dementia, 9780199764181
Paperback
Unlocking early dementia: Criteria, cases, and care for aging minds.

Mild Cognitive Impairment and Dementia

definitions, diagnosis, and treatment

$98.70

  • Paperback

    416 pages

  • Release Date

    21 March 2013

Check Delivery Options

Summary

Navigating Mild Cognitive Impairment and Dementia: A Neuropsychological Approach

In 2011, landmark revisions to diagnostic criteria for Alzheimer’s disease and the introduction of criteria for Mild Cognitive Impairment (MCI) due to Alzheimer’s disease marked a new era in understanding cognitive decline. That same year, the American Psychiatric Association proposed new criteria for major and minor neurocognitive disorders, formerly known as dementia and mild cognitive impairment.

Book Details

ISBN-13:9780199764181
ISBN-10:0199764182
Series:AACN Workshop Series
Author:Glenn E. Smith, Mark W. Bondi
Publisher:Oxford University Press Inc
Imprint:Oxford University Press Inc
Format:Paperback
Number of Pages:416
Release Date:21 March 2013
Weight:544g
Dimensions:229mm x 152mm x 28mm
What They're Saying

Critics Review

“I wanted to take a moment to publicly congratulate Glenn Smith and Mark Bondi on their text Mild Cognitive Impairment and Dementia, part of the AACN/Oxford Workshop Series. Every so often, a book comes out that represents kind of a ‘hallmark’ for our field: this is one such book. In my opinion, it is without rival on the topic of MCI and Dementia and it should be on the bookshelf of every neuropsychologist and their students. To me, it representsanother shining example of the wonderful educational resources (e.g., conferences, workshop series of books) put forth by AACN. Congratulations to the authors and the editors!” – Robert L Heilbronner, AssistantProfessor of Clinical Psychiatry and Behavioral Sciences, Northwestern University

About The Author

Glenn E. Smith

Glenn E. Smith, Ph.D., ABPP/CN, is a board-certified clinical neuropsychologist and Professor of Psychology at Mayo Clinic in Rochester MN. He has served as principal investigator of the Mayo Alzheimer’s Disease Research Center Education Core and is Associate Director of Mayo’s Clinical and Translational Science Education Resource. Dr. Smith has had continuous research funding since 1994 and has authored or co-authored over 180 original articles on normal aging, mild cognitive impairment, and dementia. He is past president of the American Board of Clinical Neuropsychology and of the Division of Clinical Neuropsychology of the American Psychological Association. In addition to supervising post-doctoral fellows, he maintains an active diagnostic neuropsychology practice. He led development of and directs Mayo’s Dementia Behavior Assessment and Response Team and HABIT (Healthy Action to Benefit Independence and Thinking) program for persons with Mild Cognitive Impairment.

Mark W. Bondi, Ph.D., ABPP/CN, is a board-certified clinical neuropsychologist, Professor of Psychiatry at the University of California San Diego, and Director of the Neuropsychological Assessment Unit at the VA San Diego Healthcare System. He is recipient of a Mid-Career Investigator Award in Patient-Oriented Research from the National Institute on Aging. His NIH funded research centers on the cognitive and brain changes of individuals at risk for dementia, and he has published more than 120 articles, books, and book chapters. Dr. Bondi is a Fellow of the American Psychological Association and National Academy of Neuropsychology, former Secretary APA’s Division of Clinical Neuropsychology, and serves on the Board of Directors of the American Board of Clinical Neuropsychology and Board of Governors of the International Neuropsychological Society. Dr. Bondi maintains a clinical practice in neuropsychology, and he is an active teacher and supervisor for his institution’s doctoral training, predoctoral internship, and postdoctoral fellowship programs.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.